Who owns INMED PHARMACEUTICALS INC?
- Ticker: INM
- CUSIP Number: 457637601
Tip: Access positions for across all investors
Analyze quarterly positions in Inmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inmed Pharmaceuticals stock
Who bought or sold INMED PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 267k | $97k | 100% | Mar 2024 |
|
| Two Sigma Securities | 15k | $5.6k | 20% | Mar 2024 |
|
| Citadel Advisors | 13k | $4.5k | -63% | Mar 2024 |
|
| BFSG | 200.00 | $73.000000 | 100% | Mar 2024 |
|
| Qube Research & Technologies | 200.00 | $70.000000 | 100% | Mar 2024 |
|
| Bank of America Corporation | 100.00 | $36.000000 | 0% | Mar 2024 |
|
| AdvisorNet Financial | 80.00 | $29.000000 | 100% | Mar 2024 |
|
| UBS Group | 41.00 | $15.001900 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 41.00 | $12.148300 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 25.00 | $0 | 127% | Mar 2024 |
|
| AllSquare Wealth Management | 21.00 | $8.001000 | 0% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 19.00 | $6.999600 | 100% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 12.00 | $5.000400 | -40% | Dec 2023 |
|
| Global Retirement Partners | 6.00 | $1.999800 | 0% | Mar 2024 |
|
| Gables Capital Management | 1.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Inmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2023 | 27k | $18k |
| TD Waterhouse Canada | Dec 2023 | 85.00 | $43.001500 |
| Advisory Services Network | Dec 2023 | 59.00 | $24.998300 |